Margaret Echerd - 16 Jun 2021 Form 4 Insider Report for Vaxart, Inc. (VXRT)

Role
SVP, Principal Accntng Officer
Signature
/s/ Margaret Echerd
Issuer symbol
VXRT
Transactions as of
16 Jun 2021
Net transactions value
$0
Form type
4
Filing time
17 Jun 2021, 16:24:47 UTC
Previous filing
14 Jun 2021
Next filing
21 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VXRT Stock Option (right to buy) Award $0 +100,000 $0.000000 100,000 16 Jun 2021 Common stock 100,000 $6.27 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option grant was approved by the board of directors of Vaxart, Inc. on March 25, 2021, subject to stockholder approval of an amendment to the Vaxart, Inc. 2019 Equity Incentive Plan, under which the stock option was granted. Vaxart, Inc.'s stockholders approved the plan amendment on June 16, 2021.
F2 The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 25, 2022, the first anniversary of the date that the grant was approved by the board of directors, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 25, 2025.